Tablets from the affected lot may exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen.
This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.
View Full Details Of The Original MedWatch Notice Here.
